Evidence map›Paper›PMID 40723279›Full record

ArticleCancers2025

Diagnostic Accuracy and Interrater Agreement of FDG-PET/CT Lymph Node Staging in High-Risk Endometrial Cancer: The SENTIREC-Endo Study.

Jorun Holm, André Henrique Dias, Oke Gerke, Annika Loft, Kirsten Bouchelouche, Mie Holm Vilstrup, Sarah Marie Bjørnholt, Sara Elisabeth Sponholtz, Kirsten Marie Jochumsen, Malene Grubbe Hildebrandt and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jorun HolmDepartment of Nuclear Medicine, Odense University Hospital, 5000 Odense, Denmark.ORCID 0000-0003-3607-8232
André Henrique DiasDepartment of Nuclear Medicine and PET-Centre, Aarhus University Hospital, 8200 Aarhus, Denmark.ORCID 0000-0003-3184-3468
Oke GerkeDepartment of Nuclear Medicine, Odense University Hospital, 5000 Odense, Denmark.ORCID 0000-0001-6335-3303
Annika LoftDepartment of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital, 2200 Copenhagen, Denmark.
Kirsten BoucheloucheDepartment of Nuclear Medicine and PET-Centre, Aarhus University Hospital, 8200 Aarhus, Denmark.
Mie Holm VilstrupDepartment of Radiology and Nuclear Medicine, Esbjerg and Grindsted Hospitals, 6700 Esbjerg, Denmark.
Sarah Marie BjørnholtDepartment of Clinical Medicine, Aarhus University, 8200 Aarhus, Denmark.
Sara Elisabeth SponholtzDepartment of Gynecology and Obstetrics, Odense University Hospital, 5000 Odense, Denmark.
Kirsten Marie JochumsenDepartment of Clinical Research, University of Southern Denmark, 5000 Odense, Denmark.ORCID 0000-0002-2758-9332
Malene Grubbe HildebrandtDepartment of Nuclear Medicine, Odense University Hospital, 5000 Odense, Denmark.ORCID 0000-0003-2720-9018
Pernille Tine JensenDepartment of Clinical Medicine, Aarhus University, 8200 Aarhus, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

diagnostic accuracyFDG-PET/CThigh-risk endometrial cancerinterrater agreementlymph node staging

Identifiers

PMID40723279
PMCPMC12293347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.